Xu D - Search Results

1

γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.

Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD. Blink SE, et al. Among authors: xu d. Cell Immunol. 2014 Jul;290(1):39-51. doi: 10.1016/j.cellimm.2014.04.013. Epub 2014 May 10. Cell Immunol. 2014. PMID: 24860937 Free PMC article.

2

Tolerance strategies employing antigen-coupled apoptotic cells and carboxylated PLG nanoparticles for the treatment of type 1 diabetes.

Prasad S, Xu D, Miller SD. Prasad S, et al. Among authors: xu d. Rev Diabet Stud. 2012 Winter;9(4):319-27. doi: 10.1900/RDS.2012.9.319. Epub 2012 Dec 28. Rev Diabet Stud. 2012. PMID: 23804269 Free PMC article. Review.

3

Immune mechanisms in epileptogenesis.

Xu D, Miller SD, Koh S. Xu D, et al. Front Cell Neurosci. 2013 Nov 8;7:195. doi: 10.3389/fncel.2013.00195. eCollection 2013. Front Cell Neurosci. 2013. PMID: 24265605 Free PMC article. Review.

4

Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Xu D, Prasad S, Miller SD. Xu D, et al. Diabetes Manag (Lond). 2013 Sep 1;3(5):415-426. doi: 10.2217/dmt.13.36. Diabetes Manag (Lond). 2013. PMID: 24505231 Free PMC article.

5

Targeting the GM-CSF receptor for the treatment of CNS autoimmunity.

Ifergan I, Davidson TS, Kebir H, Xu D, Palacios-Macapagal D, Cann J, Rodgers JM, Hunter ZN, Pittet CL, Beddow S, Jones CA, Prat A, Sleeman MA, Miller SD. Ifergan I, et al. Among authors: xu d. J Autoimmun. 2017 Nov;84:1-11. doi: 10.1016/j.jaut.2017.06.005. Epub 2017 Jun 20. J Autoimmun. 2017. PMID: 28641926 Free PMC article.

6

Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA. Jeong SJ, et al. Among authors: xu d. Neurobiol Dis. 2017 Dec;108:73-82. doi: 10.1016/j.nbd.2017.08.006. Epub 2017 Aug 18. Neurobiol Dis. 2017. PMID: 28823935 Free PMC article.

7

Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.

Prasad S, Neef T, Xu D, Podojil JR, Getts DR, Shea LD, Miller SD. Prasad S, et al. Among authors: xu d. J Autoimmun. 2018 May;89:112-124. doi: 10.1016/j.jaut.2017.12.010. Epub 2017 Dec 16. J Autoimmun. 2018. PMID: 29258717 Free PMC article.

8

Peripherally derived T regulatory and γδ T cells have opposing roles in the pathogenesis of intractable pediatric epilepsy.

Xu D, Robinson AP, Ishii T, Duncan DS, Alden TD, Goings GE, Ifergan I, Podojil JR, Penaloza-MacMaster P, Kearney JA, Swanson GT, Miller SD, Koh S. Xu D, et al. J Exp Med. 2018 Apr 2;215(4):1169-1186. doi: 10.1084/jem.20171285. Epub 2018 Feb 27. J Exp Med. 2018. PMID: 29487082 Free PMC article.

9

Intravenous Immunomodulatory Nanoparticle Treatment for Traumatic Brain Injury.

Sharma S, Ifergan I, Kurz JE, Linsenmeier RA, Xu D, Cooper JG, Miller SD, Kessler JA. Sharma S, et al. Among authors: xu d. Ann Neurol. 2020 Mar;87(3):442-455. doi: 10.1002/ana.25675. Epub 2020 Jan 22. Ann Neurol. 2020. PMID: 31925846 Free PMC article.

10

PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.

Xu D, Bhattacharyya S, Wang W, Ifergan I, Wong MAC, Procissi D, Yeldandi A, Bale S, Marangoni RG, Horbinski C, Miller SD, Varga J. Xu D, et al. JCI Insight. 2022 Mar 8;7(5):e151037. doi: 10.1172/jci.insight.151037. JCI Insight. 2022. PMID: 35104243 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,004 results

Search Page

Filters